A carregar...
Hepatocellular carcinoma decreases the chance of successful hepatitis C virus therapy with direct-acting antivirals
BACKGROUND & AIMS: The approval of all-oral direct-acting antiviral (DAA) regimens for the treatment of hepatitis C virus (HCV) has led to the expansion of therapy to include patients with cirrhosis who have hepatocellular carcinoma (HCC). Data on the use of DAAs in HCV+ patients with HCC is lim...
Na minha lista:
| Publicado no: | J Hepatol |
|---|---|
| Main Authors: | , , , , , |
| Formato: | Artigo |
| Idioma: | Inglês |
| Publicado em: |
2017
|
| Assuntos: | |
| Acesso em linha: | https://ncbi.nlm.nih.gov/pmc/articles/PMC5776681/ https://ncbi.nlm.nih.gov/pubmed/28161470 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1016/j.jhep.2017.01.020 |
| Tags: |
Adicionar Tag
Sem tags, seja o primeiro a adicionar uma tag!
|